🇺🇸 FDA
Pipeline program

Coenzyme Q10 and Lisinopril

PITT0908

Phase 3 small_molecule completed

Quick answer

Coenzyme Q10 and Lisinopril for Duchenne Muscular Dystrophy is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Duchenne Muscular Dystrophy
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials